About this trial
This randomized controlled trial aims to evaluate the efficacy of High-Intensity Laser Therapy (HILT) and Focused Extracorporeal Shock Wave Therapy (fESWT) in reducing pain in patients with plantar fasciitis. The study also examines the effects of HILT and fESWT on health-related outcomes, including VAS-FA, FFI, plantar fascia thickness, and adverse events.
Researchers will compare HILT with fESWT as treatment options for patients with plantar fasciitis.
Participants will receive either HILT or fESWT along with an exercise program. They will attend follow-up visits to assess outcomes at 1, 2, 3, 6, and 12 weeks after the first treatment.
Eligibility criteria
Qualifiers
Patients aged 18-70 years
Pain was worse in the initial step after and an extended period of rest
Pain was decreased initially after the first steps but exacerbated with increased activity
VAS ≥ 4
Disqualifiers
Have Wound/Infection/tumor in treatment area
History of foot trauma in 3 months
History of intervention at plantar fascia in 6 months such as Ultrasound therapy, steroid injection, surgery or botulinum toxin injection
Pain medication within one week before participation
Trial design
Treatments tested in this trial
- High power Laser therapy
- Focused extracorporeal shock wave therapy